31/10/2022
The wet lab study analysis for the Omicron XBB Subvariant has been completed and submitted to MOH. The result shows that Flowflex has the same sensitivity in testing the Omicron XBB Subvariant.
As a result, users of Flowflex can be assured that Flowflex has met regulatory requirements in Singapore on the ART ability to detect Omicron XBB Subvariant.